Protagenic Therapeutics Files 8-K
Ticker: PTIXW · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, security-holder-rights
Related Tickers: PTIX
TL;DR
Protagenic Therapeutics filed an 8-K on 6/24/25 for security holder rights and financials.
AI Summary
On June 24, 2025, Protagenic Therapeutics, Inc. filed an 8-K report detailing material modifications to the rights of security holders and financial statements. The company, formerly known as Atrinsic, Inc., MPLC, Inc., and NEW MOTION, INC., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates significant changes affecting Protagenic Therapeutics' security holders and provides updated financial information, which is crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K report, which typically contains factual information about corporate events and does not inherently signal high risk.
Key Numbers
- 001-12555 — SEC File Number (Identifies the company's filing with the SEC.)
- 06-1390025 — EIN (Employer Identification Number for Protagenic Therapeutics, Inc.)
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer of the 8-K report
- June 24, 2025 (date) — Earliest event reported date
- Atrinsic, Inc. (company) — Former company name
- NEW MOTION, INC. (company) — Former company name
- MPLC, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific material modifications to the rights of security holders are detailed in this 8-K filing?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item of disclosure, but the specific details of these modifications are not provided in the excerpt.
What are the former names of Protagenic Therapeutics, Inc. mentioned in the filing?
The filing lists Protagenic Therapeutics, Inc. as formerly being known as Atrinsic, Inc., NEW MOTION, INC., and MPLC, Inc.
On what date was this 8-K report filed?
The report was filed on June 27, 2025, with the earliest event reported being June 24, 2025.
What is the Standard Industrial Classification (SIC) code for Protagenic Therapeutics, Inc.?
The SIC code listed for Protagenic Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's state of incorporation and fiscal year end?
Protagenic Therapeutics, Inc. is incorporated in Delaware, and its fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).